Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Mast-Cell

Explore clinical trials studying Leukemia, Mast-Cell. Study availability and eligibility vary by location and protocol.

43 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Mast-Cell trial results

Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details
Recruiting

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

NCT03779854

Conditions
Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, +54 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
View Trial Details
Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

NCT04996875

Conditions
Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Completed

(PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis

NCT03580655

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • The University of Kansas Cancer Center Westwood, Kansas, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details
Completed

Collecting Tissue Samples From Patients With Leukemia or Other Blood Disorders Planning to Enroll in an ECOG Leukemia Treatment Clinical Trial

NCT00897767

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Aurora Presbyterian Hospital Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 214 locations
View Trial Details
Completed

(EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies

NCT02561988

Conditions
Aggressive Systemic Mastocytosis, Disease Attributes, Hematologic Diseases, +19 more
Locations
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado Cancer Center Denver, Colorado, United States
  • Emory University Atlanta, Georgia, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM

NCT04695431

Conditions
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Hematologic Diseases, +15 more
Locations
  • Standford Cancer Center Palo Alto, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Medizinische Universitat Wien Vienna, Austria
  • Universitatmedizin Mannheim Mannheim, Baden-Wurttemberg, Germany
View Trial Details

Related conditions